Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.7B | 3.5B | 6.1B | 5.2B |
| Cost of revenue | 3.3B | 3.1B | 5.0B | 4.6B |
| Gross profit | 417M | 359M | 1.1B | 544M |
| Operating expense | ||||
| Research & development | 119M | 110M | 107M | 99M |
| Selling general and admin | 241M | 235M | 248M | 211M |
| Other operating expenses | — | — | — | — |
| Operating income | 57M | 14M | 758M | 234M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 46M | 7M | 856M | 184M |
| Tax provision | 12M | 2M | 258M | 57M |
| Net income | 34M | 5M | 598M | 127M |
| Basic EPS | 0.0 | 0 | — | 0.0 |
| Diluted EPS | 0.0 | 0 | — | 0.0 |
| Basic average shares | 3.2B | 3.0B | — | 2.9B |
| Diluted average shares | 3.2B | 3.0B | — | 2.9B |
| EBITDA | 57M | 8M | 858M | 238M |
| Net income from continuing op. | 34M | 5M | 598M | 127M |
| Minority interests | -2M | 0 | 0 | 0 |
| Preferred stock dividends | 0 | 0 | 0 | 0 |